Progress in the blood-based diagnosis of oesophageal squamous cell carcinoma (ESCC) using microRNAs: Comment on Komatsu et al. (BJC (2011) 105, 104-111)

Br J Cancer. 2023 Feb;128(3):446-447. doi: 10.1038/s41416-022-02034-8. Epub 2022 Oct 28.

Author

Charles H Lawrie^{1

2

3

4}

Affiliations

¹ Molecular Oncology Group, Biodonostia Research Institute, 20014, San Sebastian, Spain. charles.lawrie@biodonostia.org.
² IKERBASQUE, Basque Foundation for Science, Bilbao, Spain. charles.lawrie@biodonostia.org.
³ Radcliffe Department of Medicine, University of Oxford, Oxford, United Kingdom. charles.lawrie@biodonostia.org.
⁴ Sino-Swiss Institute of Advanced Technology (SSIAT), Shanghai University, Shanghai, China. charles.lawrie@biodonostia.org.

No abstract available

MeSH terms

Carcinoma, Squamous Cell* / diagnosis
Carcinoma, Squamous Cell* / genetics
Carcinoma, Squamous Cell* / pathology
Cell Line, Tumor
Esophageal Neoplasms* / diagnosis
Esophageal Neoplasms* / genetics
Esophageal Neoplasms* / pathology
Esophageal Squamous Cell Carcinoma* / diagnosis
Esophageal Squamous Cell Carcinoma* / genetics
Esophageal Squamous Cell Carcinoma* / pathology
Gene Expression Regulation, Neoplastic
Humans
MicroRNAs* / genetics

Substances

MicroRNAs